Novel methods for treating egfr-associated tumors
AssigneeGenmab A/S
InventorJens OVERGAARD
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for the treatment of an EGFR-associated tumor comprising administration, to an individual in need thereof, of an anti-EGFR antibody in combination with radiotherapy and a radiosensitising agent. In one embodiment, the treatment further comprises administration of a chemotherapeutic agent.
Claims31
A method for the treatment of an EGFR-associated tumor comprising administration, to an individual in need thereof, of an anti-EGFR antibody in combination with radiotherapy and a radiosensitizing agent.
An anti-EGFR antibody for use a medicament for the treatment of an EGFR-associated cancer, wherein said anti-EGFR antibody is to be administered in combination with radiotherapy and a radiosensitizing agent.
Use of an anti-EGFR antibody for the preparation of a medicament for the treatment of an EGFR-associated cancer, wherein said anti-EGFR antibody is to be administered in combination with radiotherapy and a radiosensitizing agent.
Dependencies are inferred from the claim text.